Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells
Received Date: May 27, 2022 / Accepted Date: Jun 23, 2022 / Published Date: Jun 24, 2022
Abstract
Movement of 78-kDa glucose-controlled protein from endoplasmic reticulum to plasma film addresses a change in outlook past its conventional capability as an ER chaperone protein. Cell surface GRP78 applies novel flagging capabilities, and instruments basic its cell surface articulation are simply arising. Obtained tamoxifen obstruction of bosom malignant growth cells is went with raised degree of csGRP78. Subsequently, the tamoxifen-safe MCF7 bosom malignant growth cells addresses a clinically pertinent model to concentrate on components of csGRP78 articulation.
Citation: Cao J (2022) Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells. Breast Can Curr Res 7: 164. Doi: 10.4172/2572-4118.1000164
Copyright: © 2022 Cao J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 1727
- [From(publication date): 0-2022 - Apr 05, 2025]
- Breakdown by view type
- HTML page views: 1389
- PDF downloads: 338